TASHA SCHUETTE: Open Payments
NPI 1194813642 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 75 payments from 10 companies in 2025. Trend: 2023 $370 · 2024 $875 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 33 | $324 |
| SCPHARMACEUTICALS INC. | 19 | $229 |
| Novo Nordisk Inc | 8 | $226 |
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| Amgen Inc. | 4 | $90 |
| Alnylam Pharmaceuticals Inc. | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: LEQVIO, FUROSCIX, Wegovy, FARXIGA, REPATHA, AMVUTTRA, JARDIANCE, ENTRESTO.
Industry payments across IL — which companies pay providers there.
